8.40% p.a. Early Redemption Worst of GOAL

Underlying: AstraZeneca / Johnson & Johnson / Merck & Co. SSPA/EUSIPA Product Type: Reverse Convertibles (1220) Valor: 53014155 / ISIN: CH0530141552

Last update 06.07.2020
  • Bid

    101.17 %
    Volume: 10'000

  • Ask

    102.17 %
    Volume: 10'000